search
Back to results

Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum (EKOH-MOL 2008)

Primary Purpose

Molluscum Contagiosum

Status
Completed
Phase
Phase 2
Locations
Spain
Study Type
Interventional
Intervention
Hydroxide Potassium
Placebo
Sponsored by
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Molluscum Contagiosum focused on measuring Potassium hydroxide., Molluscum Contagiosum

Eligibility Criteria

2 Years - 6 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Who are diagnosed with a molluscum contagiosum (MC) infection (clinical diagnosis).
  • Who are between the ages of two and six.
  • Whose parents or guardians have provided written informed consent for participation.

Exclusion Criteria:

  • Immunocompromised patient (congenital or acquired).
  • Patient has received other topical treatment within the last month.
  • Patient has lesions on face, neck or genital area.
  • Patient who, in the view of the attending physician, will not comply with treatment and/or scheduled visits.

Sites / Locations

  • CAP Rambla Ferran

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

KOH 10%

KOH 15%

PLACEBO

Arm Description

Treatment consists of the application of topical 10% KOH in an aqueous solution.

Treatment consists of the application of topical 15% KOH in an aqueous solution

100 milliliters of saline solution

Outcomes

Primary Outcome Measures

Efficacy (diseappearance of lesions)

Secondary Outcome Measures

Full Information

First Posted
May 4, 2011
Last Updated
September 30, 2015
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
search

1. Study Identification

Unique Protocol Identification Number
NCT01348386
Brief Title
Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum
Acronym
EKOH-MOL 2008
Official Title
Efficacy and Tolerance of the Topical Application of Potassium Hydroxide (10% and 15%) in the Treatment of Molluscum Contagiosum
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
March 2012 (Actual)
Study Completion Date
March 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

4. Oversight

5. Study Description

Brief Summary
BACKGROUND: Molluscum contagiosum is a non-serious children viral infection. Because of its natural history, being highly contagious and the aesthetic and psychotherapeutic effects of its treatment, the investigators intend to test the use of different concentrations of potassium hydroxide solution in the primary care setting. METHODS: A double blind, randomized clinical trial, in three groups of topic treatment is designed. The intended treatment consists on a daily application of potassium hydroxide in aqueous solution at 10% and 15% concentration, versus a placebo administered to the control group. 4 follow-up visits (15, 30, 45 and 60 days) are planned to evaluate treatment effectiveness and tolerance. The main target of the trial is to determine the healing rate, defined as lesion disappearance in the affected zones after the topic application of the treatment. Secondary targets are the main characteristics and evolution of the affected zone (surface, number of lesions, size and density) description, tolerance evaluation (hyperpigmentation, itching, burning, pain), recurrence rate estimation and natural evolution of lesions in the control group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Molluscum Contagiosum
Keywords
Potassium hydroxide., Molluscum Contagiosum

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
53 (Actual)

8. Arms, Groups, and Interventions

Arm Title
KOH 10%
Arm Type
Experimental
Arm Description
Treatment consists of the application of topical 10% KOH in an aqueous solution.
Arm Title
KOH 15%
Arm Type
Experimental
Arm Description
Treatment consists of the application of topical 15% KOH in an aqueous solution
Arm Title
PLACEBO
Arm Type
Placebo Comparator
Arm Description
100 milliliters of saline solution
Intervention Type
Drug
Intervention Name(s)
Hydroxide Potassium
Intervention Description
Treatment will consist of the application of topical 10% or 15% KOH in an aqueous solution for the two treatment groups, compared to a placebo-treated control group. Topical Application.
Intervention Type
Drug
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
Efficacy (diseappearance of lesions)
Time Frame
60 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Who are diagnosed with a molluscum contagiosum (MC) infection (clinical diagnosis). Who are between the ages of two and six. Whose parents or guardians have provided written informed consent for participation. Exclusion Criteria: Immunocompromised patient (congenital or acquired). Patient has received other topical treatment within the last month. Patient has lesions on face, neck or genital area. Patient who, in the view of the attending physician, will not comply with treatment and/or scheduled visits.
Facility Information:
Facility Name
CAP Rambla Ferran
City
Lleida
State/Province
Catalunya
ZIP/Postal Code
25001
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
22011376
Citation
Marsal JR, Cruz I, Teixido C, Diez O, Martinez M, Galindo G, Real J, Schoenenberger JA, Pera H. Efficacy and tolerance of the topical application of potassium hydroxide (10% and 15%) in the treatment of molluscum contagiosum: randomized clinical trial: research protocol. BMC Infect Dis. 2011 Oct 19;11:278. doi: 10.1186/1471-2334-11-278.
Results Reference
derived

Learn more about this trial

Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum

We'll reach out to this number within 24 hrs